Abiopharma

Espinoza Octavio 🟢 acquired 8 shares of LIGAND PHARMACEUTICALS INC (LGND) at $95.68 Transaction Date: Dec 31, 2025 | Filing ID: 000003

Rodman David Malcom 🟡 adjusted position in 262.8K shares (10 derivative) of Mineralys Therapeutics, Inc. (MLYS) at $35.87 ($15.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

DONNELLY WILLIAM P 🟢 acquired 2.4K shares of Quanterix Corp (QTRX) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Badawi Paul 🔴 sold 37.2K shares of Sight Sciences, Inc. (SGHT) at $7.48 Transaction Date: Jan 02, 2026 | Filing ID: 005006

HAYDEN JEREMY B. 🔴 sold 11.2K shares of Sight Sciences, Inc. (SGHT) at $7.82 Transaction Date: Jan 05, 2026 | Filing ID: 004999

Badawi David 🔴 sold 9.7K shares of Sight Sciences, Inc. (SGHT) at $7.82 Transaction Date: Jan 02, 2026 | Filing ID: 004994

Rodberg James 🔴 sold 5.0K shares of Sight Sciences, Inc. (SGHT) at $7.82 Transaction Date: Jan 05, 2026 | Filing ID: 004987

Bauerlein Alison 🔴 sold 20.5K shares of Sight Sciences, Inc. (SGHT) at $7.82 Transaction Date: Jan 05, 2026 | Filing ID: 004979

Taylor Brenton 🔴 sold 619 shares of Sight Sciences, Inc. (SGHT) at $7.48 Transaction Date: Jan 06, 2026 | Filing ID: 004972

Miles Patrick 🔴 sold 100.0K shares of Alphatec Holdings, Inc. (ATEC) at $21.01 ($2.1M) Transaction Date: Jan 05, 2026 | Filing ID: 000002

HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China

Director Lang James Paul 🟢 acquired 2.2K shares (1 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $70.31 Transaction Date: Jan 02, 2026 | Filing ID: 000007

Director Connaughton Bernadette 🔴 sold 2.0K shares of HALOZYME THERAPEUTICS, INC. (HALO) at $70.25 Transaction Date: Jan 05, 2026 | Filing ID: 000006

Snyder Mark Howard 🟡 adjusted position in 4.2K shares (1 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $70.31 Transaction Date: Jan 03, 2026 | Filing ID: 000005

Director Booth Robert F. 🟢 acquired 42.2K shares (2 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003